© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.
The drug also showed promise for colorectal and other cancers, but it might work better in combination regimens.
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
The Supreme Court justice died from complications of metastatic pancreatic cancer.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
A new CDC study leaves the question of indoor versus outdoor dining unanswered.
The pandemic raises new concerns, but it may also lead to long-lasting improvements.
The most aggressive type of skin cancer may respond to immunotherapy.
Keytruda plus chemotherapy reduced the risk of disease progression or death by 35% compared with chemotherapy alone in certain people.
New research explores how to lower the risk of heart disease in childhood cancer survivors.
Here are latest arrivals approved by the Food and Drug Administration.
A Phase 1 study on customized immunotherapy shows promise for people with lung cancer.
Quitting smoking even within two years before a lung cancer diagnosis improves survival.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.
The targeted therapy shrank tumors in more than half of people with previously treated non-small-cell lung cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
